Latest drug design News | Page 2

Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA)
New discovery: dual acting drug delivers blood cancer a lethal ‘one-two’ punch
Scientists use quantum device to slow chemical process by factor of 100bn
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
New national venture strengthens home-grown medicine outcomes
New study reveals understanding of a basic physical property of charged particles in microgravity
New study reveals understanding of basic physical property of charged particles in suspension in microgravity
“Nothing short of miraculous” – The drug offering hope to MND patients
FDA grants ‘orphan’ designation to PTX-100 for broader TCL indications
The Next Pandemic: Researchers Develop Tool to Identify Existing Drugs to Use in a Future Outbreak
NSW Government backs University-led consortium on drug discovery
Ashurst advises Perspix Biotech on market entry in AI-driven drug development
FDA approves IND for Prader-Willi syndrome study of Neuren’s NNZ-2591
EpiAxis Therapeutics and Peptilogics announce new collaboration
Future medical applications in drug design
Burnet teams up with Monash and BioCurate to develop novel HIV antivirals
New agents to combat dangerous pathogen
New orphan drug designation for Kazia Therapeutics’ paxalisib